Gut microbiota composition in chemotherapy and targeted therapy of patients with metastatic colorectal cancer/Experiment 2/Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Svetlana up on 2025-3-26

Curated date: 2025/03/24

Curator: Miss Lulu

Revision editor(s): Miss Lulu

Source: Figure 4B

Description: Results of the log2 fold change in the subgroups of bevacizumab

Abundance in Group 1: increased abundance in Bevacizumab-PD subgroup

NCBI	Quality Control	Links
Akkermansia muciniphila
Anaerostipes caccae
Bifidobacterium breve
Bifidobacterium dentium
Enterococcus avium
Enterococcus sp. FDAARGOS_553
Fusobacterium nucleatum
Haemophilus influenzae
Lacticaseibacillus paracasei
Lactobacillus delbrueckii
Limosilactobacillus fermentum
Morganella morganii
Sutterella wadsworthensis
Veillonella atypica
Limosilactobacillus vaginalis

Revision editor(s): Miss Lulu